Skip to main content
. 2021 Dec 15;11(12):2366. doi: 10.3390/diagnostics11122366

Table 2.

Risk factors for ETA receptor expression (in univariate and multivariate analysis).

Analysis: Univariate Multivariate
Risk Factor OR (95% CI), p-Value OR (95% CI), p-Value
No. of grafts 0.83 (0.13, 5.52), 0.8483 0.59 (0.06, 5.42), 0.6431
Recipient age 0.97 (0.93, 1.01), 0.1459 0.96 (0.91, 1.00), 0.0621
Male recipient 0.79 (0.24, 2.58), 0.6963 0.73 (0.20, 2.63), 0.6316
Max PRA 0.98 (0.94, 1.02), 0.3506 0.99 (0.95, 1.03), 0.5270
No. of MM HLA ABDR 1.21 (0.85, 1.72), 0.2991 1.10 (0.63, 1.93), 0.7442
Anti-HLA Abs 1.40 (0.44, 4.49), 0.5685 1.46 (0.41, 5.20), 0.5592

OR—odds ratio; CI—confidence interval; PRA—panel reactive antibody; MM—mismatch; No.—number; HLA ABDR—human leukocyte antigen A, B, DR; Abs—antibodies.